Airway Inflammation - Immune System Research

Molnupiravir has Antiviral Activity Against Influenza Virus and Multiple Coronaviruses

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Symptoms typically include fever, cough, headache, fatigue, difficulty breathing, and loss of smell…

Airway Inflammation Inflammation

PF-184 is a Potent and Selective IKK2 Inhibitor

Edward Jenner 2022-10-04

IKK (IκB kinase) is an enzyme complex that is the core element of the NF-κB cascade. The complex has two kinases (IKKα and IKKβ) and a regulatory subunit, NEMO/IKKγ. IKKα…

Airway Inflammation

BAY 61-3606 is an Orally Active and Highly Selective SYK Inhibitor for Inflammatory Diseases

Edward Jenner 2019-09-03

Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase. Syk plays an important role in allergic diseases and inflammation. Thus, Syk is an attractive target for therapeutic kinase inhibitors. This…

Molnupiravir has Antiviral Activity Against Influenza Virus and Multiple Coronaviruses

PF-184 is a Potent and Selective IKK2 Inhibitor

BAY 61-3606 is an Orally Active and Highly Selective SYK Inhibitor for Inflammatory Diseases

You Missed

PRX-08066 is an orally active 5-HT2BR Antagonist with Vasodilation Effect for PAH

Apocynin is a NADPH oxidase (NOX) Inhibitor for Metabolic and Inflammation Research

Xylometazoline is an α-adrenergic Receptor Agonist for Nose Stuffiness Research

Elafibranor is a PPARα/δ Agonist for Metabolic Disease Research